Sera Prognostics Company
Sera Prognostics develops blood tests that are predictive of preterm birth, preeclampsia, and other pregnancy complications.
Investors
.jpeg)
Technology:
Pregnancy biomarkers
Industry:
Pregnancy & Nursing
Headquarters:
Salt Lake City, Utah, United States
Founded Date:
01-01-2008
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
13
Total Funding:
$250,324,197
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021-04-28
Last Funding Type:
Series E
Register and Claim Ownership